Evaxion A/S is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, please visit our website.
Company Details
- Employees
- 61
- Founded
- -
- Address
- Dr. Neergaards Vej 5f, Hørsholm,capital Region 2970,denmark
- in****@****ech.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- evaxion-biotech.com
- Keywords
- Immunoinformatics, Bioinformatics, Infectious Diseases, Immuno-Oncology, Vaccines, Immunotherapy, Artificial Intelligence, Antigen Discovery, Neo Epitope Discovery, AI-Immunology, AI, Biotech.
- HQ
- Hørsholm, Capital Region
Evaxion A/s Questions
Evaxion A/S's website is evaxion-biotech.com
Evaxion A/S's LinkedIn profile is https://dk.linkedin.com/company/evaxion-biotech
Evaxion A/S has
61 employees.
View email and phone details for 61
employees at Evaxion A/S.
Evaxion A/S's industry is
Biotechnology Research
Evaxion A/S's top competitors are
Symphogen,
Nordic Bioscience,
Adcendo,
Io Biotech,
Bavarian Nordic,
Genmab,
Zealand Pharma,
Immudex,
Minerva Imaging,
Gubra.
Evaxion A/S's support email address is info@evaxion-biotech.com
Evaxion A/S's categories are Biotechnology Research
Evaxion A/S's founding year is 2008
